NCT00125814View on ClinicalTrials.gov

Structured Treatment Interruptions With or Without Pegylated Interferon Alpha for HIV-Infected Patients After Prolonged Viral Suppression

PHASE3TerminatedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 31, 2001

Study Completion Date

January 31, 2005

Conditions
HIV Infections
Interventions
DRUG

Interferon alfa-2b

PROCEDURE

Structured treatment interruptions

Trial Locations (1)

92140

Service de Medecine Interne, Clamart

Sponsors

Collaborators (1)

Schering-Plough
All Listed Sponsors
collaborator

Schering-Plough

INDUSTRY

lead

French National Agency for Research on AIDS and Viral Hepatitis

OTHER_GOV

NCT00125814 - Structured Treatment Interruptions With or Without Pegylated Interferon Alpha for HIV-Infected Patients After Prolonged Viral Suppression | Biotech Hunter | Biotech Hunter